Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07167719

Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges

This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently released parolees. This study will also give a preliminary indication if the treatment is associated with reliable improvements in adjustment symptoms and well-being for parolees.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Adjustment

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Francisco Homes

Los Angeles, California, 90037, United States

Location status: Recruiting

Location contact

Teresa Groth, Sister (Catholic)

CONTACT

[email protected]

+1 323-293-1111

About this study

In the proposed pilot study, residents of a reentry facility in Los Angeles, CA will be able to enroll in a course of brief (5-session) Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization. Those who choose to receive the intervention will be included in the intervention group (target N = 30). Those who choose not to receive the intervention will be given the opportunity to complete assessments at the same intervals as the intervention group (assessment only group; target N = 30). Participants will report their degree of satisfaction with the program and how much they think they benefitted from the program at postintervention. Participants will complete self-report measures of adjustment disorder symptoms, flourishing, meaning and purpose in life, and PTSD symptoms at pretreatment (baseline), posttreatment (5 weeks after baseline), and 2-month follow-up (13 weeks after baseline).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older
  • Speaks English
  • Been on parole for two years or less.
  • Score of 8.5 or higher (range 4 to 16) on the Adjustment Disorder New Module 4 (ADNM-4) screening tool (Ben-Ezra, et al., 2018).

Exclusion criteria

None

Treatment and study plan

Cognitive behavioral therapy

Behavioral

Brief Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization

Other names: CBT

Primary outcomes

  1. Adjustment Disorder New Module 20

    Time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)

    The ADNM-20 is a self-report measure consisting of two parts: a stressor list and an item list. It is a 20-item measure that ranges from 20 to 80. Participants will fill out stressors from their prison term and will then complete the items which are composed of a 4-point Likert scales from "Never" to "Often."

  2. Flourishing Scale

    Time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)

    The Flourishing Scale is an 8-item self-report measure (with a range of 8 to 56) of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose, and optimism. The scale provides a single psychological well-being score.

  3. PROMIS Meaning and Purpose Short Form 8a

    Time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)

    The PROMIS Meaning and Purpose is an 8-item self-report measure with a range of 8 to 40 that assess one's sense of life having purpose and that there are good reasons for living. Higher scores indicate hopefulness, optimism, goal-directedness, and feelings that one's life is worthy.

Secondary outcomes

  1. PTSD Checklist 5

    Time frame: From pretreatment (baseline) to the end of treatment (5 weeks after baseline)

    This is an 8-item abbreviated version of the PTSD Checklist 5, a self-report measure which ranges from 0 to 32 that assesses the DSM-5 symptoms of PTSD.

Study contacts

Contact information is provided by the study sponsor or research team.

Alyson K Zalta

CONTACT

[email protected]

949-490-2247

Joanne B DeCaro

CONTACT

[email protected]

360-903-5503

Sponsors and collaborators

Lead sponsor

University of California, Irvine

Other

Collaborators

  • Massachusetts Institute of Technology

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 11, 2025
Registry last updated
Feb 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.